The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Aim 1. To test the relationship between reward-induced dopamine (DA) release on changes in resting state functional connectivity (RSFC) in healthy subjects. In 20 healthy adults, the investigators will examine DA release (measured using positron emission tomography, PET) in the ventral striatum, thalamus, and prefrontal cortex, as previously described. Before and after the task the investigators will examine RSFC (measured using functional magnetic resonance imaging, fMRI) between these structures, which have been shown to form functional pathways serving motivation and emotion regulation in rodents and nonhuman primates. The investigators hypothesize that DA release will impact the functional relationship between these and other structures as determined by changes in RSFC.
Aim 2. To examine the relationship between dopamine release and the Reward Positivity (RewP) potential. Subjects will be presented with the option to participate in an event-related potential (ERP) study. The investigators will correlate the amount of DA release with the amplitude of the RewP potential, an ERP that is enhanced in reward versus non-reward circumstances. Based on previous studies, the investigators hypothesize that RewP amplitude will positively correlate with dopamine release in the nucleus accumbens.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
New York
-
Stony Brook, New York, États-Unis, 11794
- Health Sciences Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Healthy men and women age 18-45 who have the capacity to consent to the protocol.
- Ability to understand and follow instructions and oriented to name, time, and place.
- A negative urine pregnancy and toxicology screen
- Willingness to abstain from using aspirin, NSAIDs, or anticoagulants during the study
Exclusion Criteria:
- Left-handed or ambidextrous
- History of seizures
- History of strokes
- Clinically significant, uncontrolled liver, kidney, cardiac, or pulmonary disease
- Terminal medical diagnosis consistent with survival < 1 year
- Serious mental impairment. Mini mental state exam of < 23/30
- Current or past DSM-IV Axis I or neurologic disorders
- Actively abusing substances, including alcohol (regular alcohol use during the past 6 months equal to or greater than 16 cans of beer per week or equivalent; use of street drugs or regular tobacco use during the past 6 months)
- Unstable medical condition (≥ 3 months), or serious medical illnesses during the past three months (e.g., serious infections)
- Unexplained loss of consciousness; history of traumatic brain injury involving loss of consciousness greater than 2 minutes
- Currently pregnant or breastfeeding, sexually active and of child-bearing potential and not using adequate contraceptive methods
- Childbirth or miscarriage during past 6 months, breastfeeding within 6 months of recruitment
- Allergic to latex and/or study pharmaceuticals
- Diabetes and/or unable to fast for up to 7 hours
- Unable to lie comfortably in the scanner for up to 4 consecutive hours
- Would receive a total of over 5 rems to a radiosensitive organ (bone marrow, gonads, lens of the eye) or 15 rems to any other organ or to the body as a whole during a 12 month period
- Contraindications for MRI including neurostimulators, implanted medical devices, metal in the body, claustrophobia, weight over 440 pounds, and girth size incompatible for scanner bore.
- Participation in a similar Social Feedback Task within 2 months of the start of the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dopamine receptor binding potential
Délai: 1-3 weeks
|
changes in dopamine receptor binding potential will be measured during and after a reward task or social stimulus task
|
1-3 weeks
|
|
Resting state fMRI
Délai: 1-3 weeks
|
Resting state functional connectivity will be measured using fMRI
|
1-3 weeks
|
|
Event-related potential (ERP) during reward
Délai: 1-3 weeks
|
ERP during a reward task is measured
|
1-3 weeks
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- PET/MR Pilot
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur En bonne santé
-
AstraZenecaParexelComplété